货号:A199997
同义名:
NSC 55929; E-Mycin
Erythromycin is an antibiotic used for the treatment of a number of bacterial infections, used for the treatment of a number of bacterial infections.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Erythromycin is a macrolide antibiotic produced by actinomycete Streptomyces erythreus with a broad spectrum of antimicrobial activity[3]. Erythromycin inhibited growth of P. falciparum with IC50 and IC90 values of 58.2 ± 7.7 microM and 104.0 ± 10.8 microM, respectively. Combinations of chloroquine with erythromycin showed synergistic effects against parasite growth in vitro[4]. The most common side effect of erythromycin is gastrointestinal intolerance, which appears to be related to disruption of intestinal motility[5]. First generation derivatives such as 2'-esters and acid-addition salts significantly improved the chemical stability and oral bioavailability of erythromycin[6]. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT02757534 | Gastroparesis | Phase 2 | Enrolling by invitation | December 2020 | United States, Iowa ... 展开 >> University of Iowa Iowa City, Iowa, United States, 52242 收起 << |
NCT01173133 | - | Unknown | December 2010 | United States, California ... 展开 >> Mills Penisula Hospital Recruiting Burlingame, California, United States, 94010-3282 Contact: John Griffin, MD 650-348-1503 Principal Investigator: John Griffin, MD 收起 << | |
NCT01424254 | Gastrointestinal Bleeding | Phase 3 | Completed | - | Canada, Quebec ... 展开 >> Montreal General Hospital Montreal, Quebec, Canada, H3G1A4 收起 << |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
1.36mL 0.27mL 0.14mL |
6.81mL 1.36mL 0.68mL |
13.63mL 2.73mL 1.36mL |
CAS号 | 114-07-8 |
分子式 | C37H67NO13 |
分子量 | 733.93 |
SMILES Code | C[C@@H]([C@@H]([C@H](C(O[C@@H]([C@@](O)([C@@H]([C@H](C([C@@H](C[C@]1(O)C)C)=O)C)O)C)CC)=O)C)O[C@H]2C[C@](C)([C@H]([C@@H](O2)C)O)OC)[C@H]1O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O |
MDL No. | MFCD00084654 |
别名 | NSC 55929; E-Mycin; Eryc-250; Eryc-125; HSDB 3074 |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry,2-8°C |